BIIB vs SSNC · P/E 21, rev $9.89B vs P/E 21, rev $3.34B
Biogen Inc (BIIB) versus SS&C Technologies Holdings Inc (SSNC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
SS&C Technologies Holdings Inc (SSNC) is a software - application company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported SSNC revenue for 2026-06-30 was $3.34B. Net income was $460.9M. SSNC currently screens at market cap $15.98B and trailing P/E 20.6.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SSNC currently screens at market cap $15.98B and trailing P/E 20.6.
Not investment advice. Open the BIIB and SSNC stock pages for the full models.
Not investment advice.